Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis

by de Borst, Martin H., Nauta, Ferdau L., Vogt, Liffert, Laverman, Gozewijn D., Gansevoort, Ron T., Navis, Gerjan
Published 2012

The Association of Albuminuria With Tubular Reabsorption of Uric Acid: Results From a General Population Cohort

by Scheven, Lieneke, Joosten, Michel M., de Jong, Paul E., Bakker, Stephan J. L., Gansevoort, Ron T.
Published 2014

The Association of APOE Genotype with Cognitive Function in Persons Aged 35 Years or Older

by Izaks, Gerbrand J., Gansevoort, Ron T., van der Knaap, Aafke M., Navis, Gerjan, Dullaart, Robin P. F., Slaets, Joris P. J.
Published 2011

The Interaction of Age and Type 2 Diabetes on Executive Function and Memory in Persons Aged 35 Years or Older

by van Eersel, Marlise E. A., Joosten, Hanneke, Gansevoort, Ron T., Dullaart, Robin P. F., Slaets, Joris P. J., Izaks, Gerbrand J.
Published 2013

Predictors of Progression in Albuminuria in the General Population: Results from the PREVEND Cohort

by Scheven, Lieneke, Halbesma, Nynke, de Jong, Paul E., de Zeeuw, Dick, Bakker, Stephan J. L., Gansevoort, Ron T.
Published 2013

Differences between physicians in the likelihood of referral and acceptance of elderly patients for dialysis influence of age and comorbidity

by Visser, Annemieke, Dijkstra, Geke J., Huisman, Roel M., Gansevoort, Ron T., de Jong, Paul E., Reijneveld, Sijmen A.
Published 2008

Statin Use and Cognitive Function: Population-Based Observational Study with Long-Term Follow-Up

by Joosten, Hanneke, Visser, Sipke T., van Eersel, Marlise E., Gansevoort, Ron T., Bilo, Henk J. G., Slaets, Joris P., Izaks, Gerbrand J.
Published 2014

Longitudinal Study of Performance on the Ruff Figural Fluency Test in Persons Aged 35 Years or Older

by van Eersel, Marlise E. A., Joosten, Hanneke, Koerts, Janneke, Gansevoort, Ron T., Slaets, Joris P. J., Izaks, Gerbrand J.
Published 2015

Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes

by Nauta, Ferdau L., Boertien, Wendy E., Bakker, Stephan J.L., van Goor, Harry, van Oeveren, Wim, de Jong, Paul E., Bilo, Henk, Gansevoort, Ron T.
Published 2011

Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes

by Hellemons, Merel E., Mazagova, Magdalena, Gansevoort, Ron T., Henning, Robert H., de Zeeuw, Dick, Bakker, Stephan J.L., Lambers-Heerspink, Hiddo J., Deelman, Leo E.
Published 2012

Validity of (Ultra-)Short Recordings for Heart Rate Variability Measurements

by Munoz, M. Loretto, van Roon, Arie, Riese, Harriëtte, Thio, Chris, Oostenbroek, Emma, Westrik, Iris, de Geus, Eco J. C., Gansevoort, Ron, Lefrandt, Joop, Nolte, Ilja M., Snieder, Harold
Published 2015

Physical Activity Is not Associated with Estimated Glomerular Filtration Rate among Young and Middle-Aged Adults: Results from the Population-Based Longitudinal Doetinchem Study

by Herber-Gast, Gerrie-Cor M., Hulsegge, Gerben, Hartman, Linda, Verschuren, W. M. Monique, Stehouwer, Coen D. A., Gansevoort, Ron T., Bakker, Stephan J. L., Spijkerman, Annemieke M. W.
Published 2015

Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients?

by Ettema, Esmée M., Kuipers, Johanna, Assa, Solmaz, Bakker, Stephan J. L., Groen, Henk, Westerhuis, Ralf, Gaillard, Carlo A. J. M., Gansevoort, Ron T., Franssen, Casper F. M.
Published 2015

β2‐Microglobulin, Cystatin C, and Creatinine and Risk of Symptomatic Peripheral Artery Disease

by Joosten, Michel M., Pai, Jennifer K., Bertoia, Monica L., Gansevoort, Ron T., Bakker, Stephan J. L., Cooke, John P., Rimm, Eric B., Mukamal, Kenneth J.
Published 2014

Kidney function, albuminuria and life expectancy

by Turin, Tanvir Chowdhury, Ahmed, Sofia B, Tonelli, Marcello, Manns, Braden, Ravani, Pietro, James, Matthew, Quinn, Robert R, Jun, Min, Gansevoort, Ron, Hemmelgarn, Brenda
Published 2014

Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease – The Doetinchem Cohort Study

by Hulsegge, Gerben, Spijkerman, Annemieke M. W., van der Schouw, Yvonne T., Bakker, Stephan J. L., Gansevoort, Ron T., Smit, Henriette A., Verschuren, W. M. Monique
Published 2016

One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and Chronic Kidney Disease

by Alssema, Marjan, Newson, Rachel S., Bakker, Stephan J.L., Stehouwer, Coen D.A., Heymans, Martijn W., Nijpels, Giel, Hillege, Hans L., Hofman, Albert, Witteman, Jacqueline C.M., Gansevoort, Ron T., Dekker, Jacqueline M.
Published 2012

Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31)

by Riphagen, Ineke J., Boertien, Wendy E., Alkhalaf, Alaa, Kleefstra, Nanne, Gansevoort, Ron T., Groenier, Klaas H., van Hateren, Kornelis J.J., Struck, Joachim, Navis, Gerjan, Bilo, Henk J.G., Bakker, Stephan J.L.
Published 2013

Liver Function Tests and Risk Prediction of Incident Type 2 Diabetes: Evaluation in Two Independent Cohorts

by Abbasi, Ali, Bakker, Stephan J. L., Corpeleijn, Eva, van der A, Daphne L., Gansevoort, Ron T., Gans, Rijk O. B., Peelen, Linda M., van der Schouw, Yvonne T., Stolk, Ronald P., Navis, Gerjan, Spijkerman, Annemieke M. W., Beulens, Joline W. J.
Published 2012

A Genome-Wide Association Study of Circulating Galectin-3

by de Boer, Rudolf A., Verweij, Niek, van Veldhuisen, Dirk J., Westra, Harm-Jan, Bakker, Stephan J. L., Gansevoort, Ron T., Muller Kobold, Anneke C., van Gilst, Wiek H., Franke, Lude, Leach, Irene Mateo, van der Harst, Pim
Published 2012